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tropic support (p<0.01).
Conclusion: HFABP is a rapid marker for assessment of myocardial damage and clinical
outcome in pediatric cardiac surgery. In particular, serum HFABP levels immediately after
an aortic declamping may be a potentially useful prognostic indicator of myocardial dam-
age as well as clinical outcome in pediatric cardiac surgery. 
1039-205 Partial Anomalous Pulmonary Venous Connection: 
Warden Versus Non-Warden in a Contemporaneous 
Surgical Cohort
Camille L. Hancock Friesen, Andrea Schnell, Kimberlee Gauvreau, Pedro J. del Nido, 
Joseph M. Forbess, Richard A. Jonas, John E. Mayer, Jr., J. Keane, Michael F. Flanagan, 
Emile Bacha, Children's Hospital Boston, Boston, MA
Background: The Warden procedure for repair of right-sided partial anomalous pulmo-
nary venous connection (PAPVC) comprises dividing the SVC above the anomalous pul-
monary veins, over sewing the proximal SVC stump, anastomosis of the distal SVC to the
right atrial appendage and baffling of the pulmonary veins to the interatrial communica-
tion. We reviewed our operative series to compare the incidence systemic venous
obstruction, pulmonary venous obstruction and sinus node dysfunction (as indicated by
12 lead EKG at most recent follow up) in patients with right-sided PAPVC undergoing the
Warden procedure (W) versus a traditional baffle operation (B).
Methods: We reviewed all available data for 92 pts with right-sided PAPVC who were
operatively repaired in a single institution 01/88-12/00. The W technique was used when
one of the anomalous RPV entered the SVC cephalad to the SVC-RA junction such that
using a standard B repair would entail a long and potentially obstructing baffle.
Results: Thirty-eight pts were repaired using the W procedure, 54 had traditional B oper-
ations (39 had isolated baffle, 15 had baffle plus SVC-RA junction augmentation). Eigh-
teen pts had additional procedures. Males comprised 68.4% of the W and 46.3% of B
pts, p=0.06. Both pt cohorts were similar in age (W median 4y vs B 3y, p=0.06) and
weight at surgery (W median 14.3 kg vs B 15 kg, p=0.09). The total pump and cross
clamp times were similar between the groups. There were no early or late mortalities. W
pts had a shorter median length of stay in hospital (4 d vs 5 d, p=0.008). There was a
higher incidence of asymptomatic SVC obstruction in W pts compared with B pts (18.4%
vs 3.7%, p=0.03) with a trend to increased reintervention (2/3 were symptomatic) in the
W cohort (7.9% vs 0, p=0.07). Reintervention in 2 pts was single balloon dilation and 1 pt
required reoperation. Pulmonary vein obstruction occurred in 1/38 W vs 5/66 B pts,
p=0.4, with one pt in each group requiring reintervention. Non sinus rhythm was rare (W
1/38, B 0/54) with no patients requiring a pacemaker although the study is underpowered
to detect a difference.
Conclusions: The W procedure is associated with a higher risk of asymptomatic SVC
obstruction than the B approach.
1039-206 Determinants of Intensive Care Unit Length of Stay for 
Infants Undergoing Cardiac Surgery
Matthew J. Gillespie, Marijn Kuijpers, Maaike Van Rossem, Sarah Tabbutt, J. William 
Gaynor, Thomas L. Spray, Bernard J. Clark, III, The Children's Hospital of Philadelphia, 
Philadelphia, PA
Background: To better understand the determinants of medical cost in infants undergo-
ing cardiac surgery we determined factors that influence postoperative intensive care unit
length of stay (ICLOS).
Methods: Records of infants < 6 months of age at time of surgery from 1/2000-12/2000
were reviewed. Diagnostic and surgical severity were adjusted using the Aristotle Basic
Complexity Score (ABCS; range 1-4).
Results: Of 223 infants, 68 had elective surgery, ie admission to the CICU after surgery
and 155 had non-elective surgery with admission to the CICU preoperatively. Elective vs
non-elective groups differed: ABCS(median 2 vs 3, p<0.001), age at surgery (mean 110
+10.5 vs 27+3.7days, p<0.001), Total LOS (median 5 vs 10 days, p<0.001) ICLOS
(median 3 vs 5.5 days, p<0.002) and mortality (1.5% vs 14.5% p<.0001). Step wise mul-
tiple regression was performed using the natural log of ICLOS as the dependent variable
(R2 range .66-.76). Factors associated with longer ICLOS included: higher ABCS, total
hours of ventilatory support, total support time (TST = bypass + circulatory arrest times),
postop cardiac catheterization, postop necrotizing enterocolitis and postop NG feeds.
Higher preop weight and surgical repair vs palliation decreased ICLOS.
Conclusion: Operative and postop factors influenced ICLOS more than factors related to
preop clinical condition. The ABCS provided an efficient method of severity adjustment
for diagnosis and surgical procedures. The ABCS was significantly correlated with
ICLOS.
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1057-199 Characteristics and Outcomes of Fetuses With 
Pericardial Effusions
Timothy C. Slesnick, Nancy A. Ayres, Carolyn A. Altman, Louis I. Bezold, Benjamin W. 
Eidem, J. Kennard Fraley, Grace C. Kung, John P. Kovalchin, Baylor College of Medicine, 
Houston, TX
BACKGROUND: Limited information is known about the characteristics and outcomes of
fetuses with pericardial effusions (PCE). We sought to identify factors associated with
fetal PCE, the natural history, and outcomes of fetuses with PCE.
METHODS: We reviewed our fetal echocardiography database from 1993 to 2002, and
all pts with PCE were included in the study. Size of PCE, presence of structural heart dis-
ease, hydrops, cardiac function, arrhythmias, and extracardiac malformations were deter-
mined for each pt. Pts were divided into small (<4 mm) and large (>4 mm) PCE groups
for comparison. Follow-up and outcome data were evaluated, and comparisons were
made between survivors and nonsurvivors.
RESULTS: PCE were present in 104 fetuses (mean gestational age 28.6 ± 5.0 weeks),
including 80 small and 24 large PCE. Forty-seven pts had structural heart disease, 37
hydrops, 29 impaired cardiac function, 26 arrhythmias, and 14 extracardiac malforma-
tions. Twenty pts had PCE without any other fetal abnormalities (isolated), including 19
small and 1 large PCE. Large PCE were associated with a higher likelihood of structural
heart disease (p=0.03) and impaired function (p=0.01), but not with hydrops, arrhythmias
or extracardiac malformations. Repeat fetal echos were performed in 52 pts, with resolu-
tion of PCE in 25 pts (48%), 23 small and 2 large. Postnatal echos were performed in 45
pts, with resolution of PCE in 41 pts (91%), 30 small and 11 large. Only 4 of these pts
had postnatal PCE, all of whom had large fetal PCE. Outcome data were available for 83
pts (80%), with 26 total deaths. PCE with hydrops (p=0.05) or extracardiac malformations
(p=0.001) were associated with death. However, PCE size, structural heart disease, car-
diac function, and arrhythmias were not associated with death. Isolated PCE was associ-
ated with survival (p=0.03).
CONCLUSIONS: Large PCE in fetuses are associated with structural heart disease and
impaired cardiac function, though large PCE are not associated with death. Additionally,
fetuses with PCE in the presence of hydrops or extracardiac malformations have a high
risk of mortality. The majority of fetal PCE resolve, and fetuses with isolated PCE have a
very good prognosis.
1057-200 Maternal Hyperglycemia Acutely Improves Fetal Cardiac 
Function During Tachycardia-Induced Heart Failure
Michael R. Schmidt, Morten Smerup, Steen Kristiansen, Paul White, Keld Sorensen, 
Andrew Redington, Vibeke Hjortdal, Aarhus University Hospital, Skejby, Aarhus, 
Denmark, Hospital for Sick Children, Toronto, Canada
Introduction: Sustained fetal tachycardia may lead to cardiac failure, hydrops, and
intrauterine death. We have previously shown that glucose-insulin infusion improves fetal
cardiac function during tachycardia. Maternal hyperglycemia induces fetal hyperinsuline-
mia and may be a therapeutic strategy.
Hypothesis: We hypothesized that cardiac function during fetal tachycardia can be
improved by induced maternal hyperglycemia.
Methods: 7 control fetuses and 5 hyperglycemia (HG) fetuses (all 7-10 days preterm)
from 6 pregnant sows were studied. LV pressure was measured using a 1.4F high fidelity
pressure catheter positioned in the LV via the left carotid artery. Systolic function was
measured as dP/dtmax. Fetal pacing was established with a1F pace catheter placed in
the RV through the left internal jugular vein. Fetuses were paced at 300 ± 30 bpm for 3
hours. During investigation of control fetuses, sows received saline infusion. In HG
fetuses, maternal 20% glucose infusion was initiated after 1 hour and maternal blood glu-
cose clamped at 15±1 mmol/l.
Results: Figure. dP/dtmaxdeclined during the first 60 min. In the control group, dP/dtmax
continued declining to 815±302 mmHg/s at 120 min and 660±299 mmHg/s at 180 min. In
contrast, systolic function improved after maternal hyperglycemia was induced in the HG
Variable Coefficient t value p value
postop cath 0.996 5.983 0.000
Mech vent time 0.001 5.575 0.000
total support time 0.003 2.702 0.008
Complexity Score 0.111 1.939 0.05
preop weight -0.082 -2.472 0.014
postop NG feeds 0.369 3.969 0.000
postop NEC 0.826 4.07 0.000
surgical repair -0.171 -2.033 0.043
